Table 47 Severity scores: severity of subcutaneous tissue necrosis and inflammatory cell infiltration 5 days post injection, for co-formulation vehicles varying in HP-B-CD content and molar substitution degree as well as in overall buffer composition Concluding Remarks The results in table 47 show that the in vivo local subcutaneous tolerability depended on the concentration of HP-B-CD and the overall buffer composition
DSSI Leadership David Uminsky (he/him) Executive Director and Research Professor, Data Science Institute Mindi Mysliwiec (she/her) Senior Director of Partnerships & Chief of Staff, Data Science Institute Susan Paykin (she/her) Senior Associate Director, Community-Centered Data Science Lilly Gullickson (she/her) Research Program Administrator David Uminsky joined the University of Chicago in September 2020 as a senior research associate and Executive Director of Data Science
Last reviewed: May 29, 2026
For reconstitution math, injection technique, stacking protocols, and side effect data, see the complete GHK-Cu dosage guide
Filling out the DD Form 1705 is straightforward with FormsPal's online PDF editor